| Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway N Pu, S Gao, H Yin, J Li, W Wu, Y Fang, L Zhang, Y Rong, X Xu, D Wang, ... Cancer letters 460, 42-53, 2019 | 77 | 2019 |
| CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer Q Chen, N Pu, H Yin, J Zhang, G Zhao, W Lou, W Wu Journal of cellular and molecular medicine 24 (15), 8674-8686, 2020 | 75 | 2020 |
| Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis N Pu, J Li, Y Xu, W Lee, Y Fang, X Han, G Zhao, L Zhang, A Nuerxiati, ... Cancer management and research, 227-238, 2018 | 49 | 2018 |
| CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer N Pu, G Zhao, H Yin, J Li, A Nuerxiati, D Wang, X Xu, T Kuang, D Jin, ... Journal of Translational Medicine 16, 1-13, 2018 | 44 | 2018 |
| Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer H Yin, N Pu, Q Chen, J Zhang, G Zhao, X Xu, D Wang, T Kuang, D Jin, ... Cell death & disease 12 (11), 1033, 2021 | 38 | 2021 |
| Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma Q Chen, H Yin, S Liu, S Shoucair, N Ding, Y Ji, J Zhang, D Wang, T Kuang, ... Journal for immunotherapy of cancer 10 (12), 2022 | 17 | 2022 |
| Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram … N Pu, H Yin, G Zhao, A Nuerxiati, D Wang, X Xu, T Kuang, D Jin, W Lou, ... Journal of Cancer 10 (24), 5935, 2019 | 17 | 2019 |
| Lymph node metastatic patterns and survival predictors based on tumor size in pancreatic ductal adenocarcinoma N Pu, Q Chen, W Gan, Y Shen, S Gao, JR Habib, H Yin, J Zhang, ... Advances in Therapy 38 (8), 4258-4270, 2021 | 12 | 2021 |
| Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70 S Gao, N Pu, H Yin, J Li, Q Chen, M Yang, W Lou, Y Chen, G Zhou, C Li, ... Therapeutic Advances in Medical Oncology 12, 1758835920953728, 2020 | 11 | 2020 |
| Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study L Zhang, J Li, H Yin, D Chen, Y Li, L Gu, Y Fu, J Chen, Z Chen, S Yang, ... Annals of the Rheumatic Diseases 82 (5), 722-724, 2023 | 10 | 2023 |
| Chemokine C‐C motif ligand 21 synergized with programmed death‐ligand 1 blockade restrains tumor growth Q Chen, H Yin, N Pu, J Zhang, G Zhao, W Lou, W Wu Cancer Science 112 (11), 4457-4469, 2021 | 10 | 2021 |
| Dihydroartemisinin alleviates skin fibrosis and endothelial dysfunction in bleomycin-induced skin fibrosis models R Li, H Yin, J Wang, D He, Q Yan, L Lu Clinical Rheumatology 40 (10), 4269-4277, 2021 | 10 | 2021 |
| The effect of primary site, functional status and treatment modality on survival in gastroenteropancreatic neuroendocrine neoplasms with synchronous liver metastasis: a US … N Pu, JR Habib, M Bejjani, H Yin, M Nagai, J Chen, B Kinny-Köster, ... Annals of Translational Medicine 9 (4), 2021 | 9 | 2021 |
| Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome Q Li, R Li, H Yin, S Wang, B Liu, J Li, M Zhou, Q Yan, L Lu Biomedicine & Pharmacotherapy 153, 113459, 2022 | 8 | 2022 |
| The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications S Liu, W Wu, Y Du, H Yin, Q Chen, W Yu, W Wang, J Yu, L Liu, W Lou, ... Molecular Cancer 22 (1), 148, 2023 | 7 | 2023 |
| A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer Q Chen, N Pu, H Yin, J Zhang, G Zhao, W Lou, W Wu Experimental Biology and Medicine 247 (2), 120-130, 2022 | 6 | 2022 |
| Cancer-associated fibroblasts in neoadjuvant setting for solid cancers Y Gu, Q Chen, H Yin, M Zeng, S Gao, X Wang Critical Reviews in Oncology/Hematology, 104226, 2023 | 5 | 2023 |
| Tumor‐associated N1 and N2 neutrophils predict prognosis in patients with resected pancreatic ductal adenocarcinoma: A preliminary study H Yin, S Gao, Q Chen, S Liu, S Shoucair, Y Ji, W Lou, J Yu, W Wu, N Pu MedComm 3 (4), 2022 | 5 | 2022 |
| Current status and future perspectives of clinical research in pancreatic cancer: Establishment of evidence by science N Pu, H Yin, Q Chen, J Zhang, W Wu, W Lou Journal of Hepato‐Biliary‐Pancreatic Sciences 29 (7), 741-757, 2022 | 5 | 2022 |
| Identification of an immune-related bat signature for predicting adjuvant chemotherapy response and overall survival in patients with resected ductal adenocarcinoma of the pancreas N Pu, Q Chen, H Yin, J Zhang, G Zhao, JR Habib, J Chen, J Yu, W Lou, ... Journal of Gastrointestinal Surgery 26 (4), 869-886, 2022 | 5 | 2022 |
